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Abstract 
Purpose: To develop an ultra-high performance liquid chromatography (UPLC) - photodiode array 
(PDA) method to compare the chemical composition of two different medicinal components of 
Pterocephalus hookeri.  
Methods: Samples were chromatographically separated in succession using Waters Acquity UPLCR 
BEH C18 column (2.1 × 100 mm, 1.7 μm) and gradient elution (0.2 % phosphoric acid aqueous -
acetonitrile). Using partial least squares discriminant analysis and one-way analysis of variance, 
attempts were made to distinguish different medicinal parts of P. hookeri.  
Results: Regression equation for 10 compounds showed good linear regression (R2 > 0.9994). The 
relative standard deviations of precision, stability, repeatability and recovery were under 5 %. Compared 
with the aerial plant part, the root had significantly higher levels of sylvestroside I (p < 0.01), 
cantleyoside (p < 0.001), dipsanosides B (p < 0.01) and dipsanosides A (p < 0.01), but significantly 
lower levels of loganic acid (p < 0.001), chlorogenic acid (p < 0.01), and isochlorogenic acid (p < 0.01). 
There were no significant differences between loganin, sweroside and isochlorogenic acid C. 
Conclusion: The described method is simple, accurate and reproducible, and can be used for the 
simultaneous determination of 10 major compounds of P. hookeri. The results demonstrate that there is 
variation in the chemical composition of the aerialpart and root of P. hookeri and that loganic acid and 
cantleyoside are the primary chemical biomarkers. 
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Pterocephali herba is the whole herb of the 
perennial plant Pterocephalus hookeri (C.B. 
Clarke) Höeck, a member of the Dipsacaceae 
family [1]. In Tibetan, P. hookeri is called “Bang-
zi-du-wu,” and it is recorded as a Tibetan medical 
classic named “rGyud-bZhi” (usually known as 
the Four Tantras) [2,3] in “Drug Standards of 
Tibetan Medicines” [4] and the 2015 edition of 
the Chinese Pharmacopoeia [5]. As a traditional 
national medicine, P. hookeri has been widely 
used in many Tibetan herbal medicine 
formulations and is clinically used to treat 
diseases including common cold, rheumatoid 
arthritis, enteritis, dysentery, and other conditions 
[6,7].  
 
Tang et al 
Trop J Pharm Res, June 2017; 16(6): 1408  
 
Recent studies indicate that the main effective 
components of P. hookeri are glycosides, 
including iridoid glycosides (loganin and 
cantleyoside) and triterpenoid saponins 
(hookerosides A-D) [2,7,8]. Zhang et al [9] 
demonstrated that P. hookeri exhibit anti-
inflammatory properties. To date, several 
analytical approaches including high-
performance liquid chromatography (HPLC) [10], 
capillary zone electrophoresis [11], and ultra-fast 
liquid chromatography (UFLC) [12] have been 
used to quantify one compound or 
simultaneously quantify several compounds in P. 
hookeri. Partial least squares discriminant 
analysis (PLS-DA) is a supervised model based 
on dummy variable classification that can show 
the distribution and correlation between sample 
groups and has been used to distinguish 
between different species and identify potential 
biomarkers [13,14]. As far as we know, there is 
no publication describing the use of PLS-DA and 
simultaneous quantitation of 10 compounds to 
distinguish between different medicinal parts of 
P. hookeri. 
 
Here we exploit a quick, dependable, and 
reproducible UPLC-PDA method for the 
simultaneous quantitative assay of 10 
compounds in two different medicinal plant parts 




Materials and reagents 
 
Acetonitrile (HPLC grade) was purchased from 
Merck (Darmstadt, Germany). Deionized water 
used for UPLC was obtained with the Milli-Q 
system from Millipore (Billerica, MA, USA). Other 
used reagents were of analytical grade. 
 
The compounds (~98 %, quantification grade) of 
loganic acid (1), chlorogenic acid (2), and loganin 
(3) were obtained from the National Institutes for 
Food and Drug Control (Beijing, China). 
Sweroside (4), sylvestroside I (6), cantleyoside 
(8), dipsanosides B (9), dipsanosides A (10) 
were isolated and purified from P. hookeri by our 
research group [15-16]. Isochlorogenic acid A (5) 
and Isochlorogenic acid C (7) were provided by 
Chengdu Must Bio-Technology Co., Ltd. 
(Chengdu, China). 
 
A total of 32 batches of different plant parts of P. 
hookeri were collected from different regions of 
Sichuan and Yunnan Provinces in China, 
consisting of 16 batches each of aerial part and 
root samples. as listed in ‘Results’ section. The 
plant samples were authenticated by Professor 
Yi Zhang of College of Ethnic Medicine, Chengdu 
University of Traditional Chinese Medicine, and 
voucher specimens kept in the herbarium of 
College of Ethnic Medicine, Chengdu University 
of Traditional Chinese Medicine.  
 
Instrument and chromatographic conditions 
 
UPLC analysis was performed a Waters Acquity 
UPLC system (Waters Corp,. Milford, MA, USA), 
equipped with PDA. Acquity UPLCR BEH C18 
column (2.1×100 mm, 1.7 μm) was used. The 
mobile phase was made up of 0.2 % phosphoric 
acid aqueous (A) and acetonitrile (B). The 
gradient elution made was employed as follows: 
0 - 4 min, 10 - 12 % B; 4 - 5 min, 12 - 17 % B;  5 
- 10 min, 17 - 17 % B; 10 - 14 min, 17 - 25 % B; 
14 - 15 min, 25 - 25 % B. Detection wavelength 
was monitored at 237 and 325 nm. Flow rate, 0.4 
mL/min; injection volume, 1 μL; column 
temperature, 30 oC. 
 
Preparation of standard solutions 
 
The 10 compounds were precisely weighted and 
dissolved with 70 % methanol in a graduated 
flask to obtain mixed reference solutions of the 
following concentrations: 0.159 (1), 0.305 (2), 
0.101 (3), 0.175 (4), 0.253 (5), 0.385 (6), 0.138 
(7), 1.385 (8), 0.065 (9), and 0.130 mg/mL (10). 
The mixture solution was diluted stepwise with 
70 % methyl alcohol to make standard solutions 




All samples were smashed, and passed a 50 
mesh sieve. Powdered samples (0.5 g) were 
accurately weighed and dissolved in 70 % methyl 
alcohol (50 mL) by sonication for 30 min. 
Additional 70 % methanol was added to make up 
for lost weight. The extract was filtered through a 




Samples were analyzed with a Waters Acquity 
UPLC system. PDA was utilized for the detection 
using 237 and 325 nm. All chromatographic 
parameters were optimized for better separation, 
including mobile phase composition, flow rate, 
gradient elution mode, and column temperature.  
 
The concentrations of loganic acid (1), 
chlorogenic acid (2), loganin (3), sweroside (4), 
isochlorogenic acid A (5), sylvestroside I (6), 
isochlorogenic acid C (7), cantleyoside (8), 
dipsanosides B (9), and dipsanosides A (10) in 
every sample were calculated based on the 
established calibration curves. 
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Validation of UPLC method 
 
The UPLC-PDA method was validated in the 
terms of linearity, stability, recovery, repeatability, 
and accuracy [17]. The storage solutions of 10 
compounds were set up the regression 
equations, which were plotted after linear 
regression between the peak areas and 
concentrations of 10 compounds [18]. The limit of 
detection (LOD) and quantification (LOQ) were 
determined at signal-to- noise ratios of 3 and 10, 




The UPLC-PDA data were input to the SIMCA-P 
software package (version 12.0, Umetrics, 
Umeå, Sweden) for PLS-DA [21]. GraphPad 
Prism software (version 5.0, GraphPad Software 
Inc, San Diego, CA, USA) was used to generate 
graphs and perform one-way analysis of variance 
(ANOVA) [22]. Differences were considered 




Optimization of extraction procedure 
 
To achieve an efficient extraction of the 10 
compounds from P. hookeri, key factors including 
the method, solvent type, time, solvent volume, 
and number of extractions were independently 
investigated. A comparison of different extraction 
methods (ultrasonic, refluxing, and standing 
extraction) revealed no significant differences in 
extraction rate; however, ultrasonic extraction 
was most convenient. Methanol was a more 
efficient solvent than ethanol. The concentrations 
of three different aqueous methanol solvents (50, 
70 or 90 %) were compared, and 70 % was 
chosen. Furthermore, tests of the number of 
extractions (1, 2 or 3 times), solvent volume (30, 
50 or 70 mL), and time (20, 30 or 40 min) were 
investigated. The sample processing method 
was finally established as follows: 0.5 g sample 
was extracted with 50 mL of 70 % methanol with 
ultrasonication for 30 min. 
 
Optimized UPLC conditions 
 
Acquity UPLCR BEH C18 (2.1 mm × 100 mm, 1.7 
μm), Acquity UPLCR BEH C18 (2.1 mm × 50 
mm, 1.7 μm), and Acquity UPLCR HSS T3 (2.1 
mm × 150 mm, 1.8 μm) columns were put to test 
for their separation ability. The Acquity UPLCR 
BEH C18 column (2.1 mm × 100 mm, 1.7 μm) 
was most effective. We also compared four 
different mobile phases (methanol-water, 
acetonitrile-water, acetonitrile-0.2 % formic acid 
aqueous solution, and acetonitrile-0.2 phosphoric 
acid aqueous solution) and found that 
acetonitrile-0.2 % phosphoric acid aqueous 
solution had lower column pressure, better peak 
shape, and higher resolution than other mobile 
phases [23]. Furthermore, the chromate-graphic 
conditions were tested incorporating the flow 
velocity (0.3, 0.4 or 0.45 mL/min) and column 
temperature (25, 30 or 35 °C), and separation 
was satisfactory for 30 °C and a flow rate of 0.4 
mL/min. Based on the absorption curves of the 
tested analytes, loganic acid (1), loganin (3), 
sweroside (4), sylvestroside I (6), cantleyoside 
(8), dipsanosides B (9), and dipsanosides A (10) 
exhibited maximum absorptions at 237 nm, while 
chlorogenic acid (2), isochlorogenic acid A (5), 
and isochlorogenic acid C (7) showed maximum 
absorptions at 325 nm. Therefore, the PDA 
detection wavelengths were set at 237 and 325 
nm. The UPLC-PDA results of 10 compounds 
are displayed in Figure 1. 
 
UPLC validation data 
 
The method was validated by the guidelines for 
Validation of Quality Standard of Traditional 
Chinese Medicine [24]. Table 1 lists detailed 
information. All regression equations showed 
good linear relationships (R2 > 0.9994). LODs 
and LOQs for the 10 compounds were in the 
range of 0.12-3.35 μg/mL and 0.45-11.20 μg/mL, 
respectively. Table 2 provides detailed data on 
the precision, repeatability, and stability for 10 
compounds, relative standard deviations (RSDs) 
were in the range of 0.44-0.96, 0.42-1.43, and 
0.91-3.58, respectively. Table 3 shows the 
recovery rates for three various concentrations 
(low, middle, and high). The mean recovery rates 
were in the range of 96.62 to 100.76 %, and 
RSDs of the 10 compounds were less than 5 %. 
These findings demonstrate that the UPLC-PDA 
method is sufficiently precise and accurate for 
simultaneous quantification of 10 compounds in 
P. hookeri. 
 
Method application to samples 
 
Using the developed UPLC method, 10 
compounds were determined simultaneously in 
32 batches of different medicinal parts samples. 
Figure 1 shows representative the UPLC-PDA 
chromatograms of two different medicinal parts 
of P. hookeri. All samples were independently 
assayed three times to calculate the average 
content (mg/g), the results are shown in Table 4. 
Among the 10 compounds, dipsanosides A 
(0.30-9.52 mg/g) were more abundant than 
dipsanosides B (0.17-3.16 mg/g). In the root 
samples, the detected ranges were 1.60-9.13 
mg/g for loganic acid, 0.87-16.55 mg/g for 
chlorogenic acid, 0.47-2.09 mg/g for loganin,  
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Table 1: Regression data, LOD and LOQ of 10 compounds 
 
Compound Calibration curve R2 Linear range (μg/mL) LOD (μg/mL) LOQ (μg/mL) 
Loganic acid (1) y=2924.3 x – 2352.6 0.9994 2.48-158.75 0.51 1.75 
Chlorogenic acid (2)  y=5949.3 x – 1234.8 1.0000 9.53-305.00 0.39 1.44 
Loganin (3) y=3082.1 x – 8.3 0.9999 3.15-100.63 0.30 1.12 
Sweroside (4) y=2489.9 x – 1515.3 1.0000 5.47-175.00 1.17 3.97 
Isochlorogenic acid A (5) y=6450.9 x – 33.1 0.9997 7.89-252.50 0.12 0.45 
Sylvestroside I (6) y=2956.1 x – 19.6 1.0000 3.01-385.00 0.58 1.93 
Isochlorogenic acid C (7) y=6679.9 x – 875.9 1.0000 4.30-137.50 0.33 1.18 
Cantleyoside (8) y=2019.0 x – 6031.3 0.9999 43.28-1385.00 3.35 11.20 
Dipsanosides B (9)  y=2661.2 x – 1241.3 0.9999 2.03-65.00 0.69 2.29 
Dipsanosides A (10)  y=3249.3 x – 1439.4 0.9998 2.03-130.00 0.70 2.37 
 
Table 2: Precision, repeatability and stability of the UPLC method for determination of the 10 compounds 
 
Compound Precision (n=6)  Repeatability (n=6)  Stability (n=6) Content (mg/g) RSD (%)  Content (mg/g) RSD (%)  Content (mg/g) RSD (%) 
Loganic acid (1) 3.46 0.53  3.47 0.60  3.44 1.26 
Chlorogenic acid (2)  2.74 0.61  2.73 0.59  2.73 0.91 
Loganin (3) 2.83 0.70  2.82 0.92  2.80 1.37 
Sweroside (4) 5.44 0.55  5.44 0.46  5.43 2.23 
Isochlorogenic acid A (5) 1.64 s0.77  1.63 1.15  1.66 1.01 
Sylvestroside I (6) 26.44 0.75  26.49 0.89  26.57 0.95 
Isochlorogenic acid C (7) 3.30 0.87  3.30 0.87  3.25 1.26 
Cantleyoside (8) 56.76 0.44  56.76 0.42  56.83 0.59 
Dipsanosides B (9)  1.58 0.96  1.57 1.43  1.55 3.58 
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Loganic acid (1) 0.864 0.712 1.549 96.21 98.78 2.46 
 0.864 0.855 1.728 101.05   
 0.865 1.094 1.949 99.09   
Chlorogenic acid (2)  0.683 0.55 1.247 102.55 99.65 2.53 
 0.682 0.623 1.292 97.91   
 0.683 0.802 1.473 98.50   
Loganin (3) 0.705 0.648 1.386 102.31 97.73 1.48 
 0.705 0.734 1.449 101.36   
 0.706 0.859 1.553 98.60   
Sweroside (4) 1.361 1.09 2.428 97.89 100.76 1.91 
 1.36 1.415 2.762 99.08   
 1.362 1.608 2.909 96.21   
Isochlorogenic acid 
A (5) 
0.409 0.306 0.701 95.32 99.36 3.55 
 0.409 0.412 0.825 100.97   
 0.409 0.504 0.922 101.79   
Sylvestroside I (6) 6.554 5.332 11.785 98.11 98.86 1.79 
 6.549 6.407 12.801 97.58   
 6.559 7.477 14.102 100.88   
Isochlorogenic acid 
C (7) 
0.825 0.644 1.449 96.89 96.62 1.52 
 0.825 0.805 1.59 95.03   
 0.826 0.966 1.772 97.93   
Cantleyoside (8) 14.095 11.593 25.485 98.25 99.02 1.04 
 14.084 14.342 28.23 98.63   
 14.107 16.991 31.13 100.19   
Dipsanosides B (9)  0.392 0.294 0.673 95.58 98.73 2.87 
 0.391 0.376 0.771 101.06   
 0.392 0.455 0.845 99.56   
Dipsanosides A (10)  0.642 0.543 1.173 97.79 98.53 1.18 
 0.641 0.674 1.301 97.92   
 0.642 0.754 1.395 99.87   
 
2.04-5.10 mg/g for sweroside, 1.31-16.34 mg/g 
for isochlorogenic acid A, 0.51-10.86 mg/g for 
sylvestroside I, 1.34-9.79 mg/g for isochlorogenic 
acid C, 6.10-31.16 mg/g for cantleyoside, 0.17-
0.74 mg/g for dipsanosides B, and 0.30-2.22 
mg/g for dipsanosides A. In the root samples, 
cantleyoside always content the highest, ranging 
from 38.81 to 99.28mg/g. The contents were 
0.26-3.45 mg/g for loganic acid, 1.11-3.32 mg/g 
for chlorogenic acid, 0.33-2.82 mg/g for loganin, 
1.81-5.47 mg/g for sweroside, 1.22-4.83 mg/g for 
isochlorogenic acid A, 1.77-26.20 mg/g for 
sylvestroside I, 2.12-10.24 mg/g for 
isochlorogenic acid C, 0.33-3.16 mg/g for 





PLS-DA was applied to achieve good sample 
separation. The resulting score plot (Figure 2A) 
demonstrated that the 32 batches of different 
medicinal parts from P. hookeri could be divided 
into two groups. In addition, the PLS-DA loading 
plot (Figure 2B) showed that loganic acid and 
cantleyoside were the primary chemical 
biomarkers. To better understand sample 
contents, graphs were produced from the data in 
Table 4. Figure 3 shows that compared with the 
aerial component, the root had significantly 
higher levels of sylvestroside I, cantleyoside, 
dipsanosides B, and dipsanosides A, but 
significantly lower levels of loganic acid, 
chlorogenic acid, and isochlorogenic acid. There 
were no significant differences in loganin, 
sweroside, and isochlorogenic acid C (p > 0.05). 
 
Oleanolic acid and ursolic acid are the markers 
currently used to control P. hookeri quality. The 
2015 edition of the Chinese Pharmacopoeia 
dictates that the total contents of oleanolic acid 
and ursolic acid in should not be less than 0.20 
%. 
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Figure 1: Comparison of UPLC chromatograms for (A) standard mixture, (B) the aerial part, and (C) root of P. 
hookeri. Peaks: 1. loganic acid, 2. chlorogenic acid , 3. loganin, 4. sweroside, 5. isochlorogenic acid A, 6. 




Figure 2: Score (A) and loading (B) plots of PLS-DA of the 32 tested samples derived from UPLC 
quantitative data. “a”: the aerial part sample, “b”: the root sample 
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Table 4: Content (mg/g) of 10 compounds in plant parts of P. hookeri, determined by UPLC (n = 3) 
 
No. Voucher number Sources (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) 
S1a 2015071500401 Kajia bridge, Luhuo, 
Sichuan 
5.17 1.73 1.01 2.94 2.61 1.03 2.27 14.24 0.17 0.38 
S1b 2015071500402 1.44 1.11 0.82 2.96 1.37 5.56 2.75 62.96 0.33 0.71 
S2a 2015071704901 Changgen village, Baiyu, 
Sichuan 
3.05 1.98 1.68 3.61 1.31 3.87 1.97 29.44 0.61 1.64 
S2b 2015071704902 0.39 1.19 0.49 2.27 1.22 5.20 2.12 42.35 0.35 0.72 
S3a 2015080500801 Jiangshi country, 
Kangding, Sichuan 
9.13 2.36 2.09 5.10 2.15 1.88 1.95 16.33 0.34 0.96 
S3b 2015080500802 0.80 1.41 0.40 2.57 2.00 4.88 4.16 50.87 0.61 1.25 
S4a 2015072100201 Heiga village, Dege, 
Sichuan 
1.60 0.87 0.51 2.35 1.89 0.54 1.34 6.16 0.23 0.60 
S4b 2015072100202 0.65 1.33 1.11 5.47 2.21 5.05 2.28 38.81 1.28 2.30 
S5a 2015080501001 Gerima country, 
Kangding, Sichuan 
4.73 2.48 1.30 2.94 4.00 0.51 3.95 18.15 0.43 1.23 
S5b 2015080501002 1.04 2.20 0.54 3.52 3.02 3.16 5.47 68.03 1.02 2.62 
S6a 2015071500501 Qianjing village, Luhuo, 
Sichuan 
6.14 1.39 1.36 3.35 1.76 1.55 2.14 15.60 0.48 1.18 
S6b 2015071500502 2.06 1.96 0.90 4.91 2.35 7.99 4.59 64.33 1.09 2.35 
S7a 2015080701501 Jiaerduo country, Aba, 
Sichuan 
4.31 16.70 1.80 3.10 16.34 0.59 7.55 18.53 0.25 0.49 
S7b 2015080701502 0.26 1.27 0.42 2.53 2.58 3.30 5.18 58.04 0.37 0.65 
S8a 2015080701601 Aqiu country, Aba, 
Sichuan 
4.78 16.10 0.90 3.71 8.27 0.64 5.27 15.04 0.23 0.54 
S8b 2015080701602 0.51 1.31 0.33 1.81 2.00 2.52 5.24 48.66 0.36 0.79 
S9a 2015080800201 Xiangmuduo country, 
Aba, Sichuan 
5.33 16.55 2.02 2.92 19.10 0.72 9.79 22.78 0.34 0.84 
S9b 2015080800202 0.53 2.35 0.63 3.11 4.83 2.86 10.24 87.68 0.73 1.81 
S10a 2015080801101 Caoyuan country, Aba, 
Sichuan 
1.60 6.22 0.76 2.04 6.88 0.53 3.93 11.92 0.30 0.86 
S10b 2015080801102 0.71 1.21 1.52 3.10 2.63 1.77 5.61 66.91 1.00 3.03 
S11a 2015080802801 Exiang country, Aba, 
Sichuan 
1.69 3.89 0.76 2.40 5.24 1.69 4.24 10.85 0.43 1.24 
S11b 2015080802802 2.10 1.93 2.66 3.70 3.30 4.95 9.18 52.68 2.89 9.52 
S12a 2015080501801 Yakou, Ruoergai, Sichuan 4.50 5.32 1.13 3.70 6.92 1.54 7.25 6.10 0.67 2.22 
S12b 2015080501802 1.46 1.39 1.14 3.78 2.33 4.24 6.26 47.67 2.70 8.87 
S13a 2015080900701 Gemo country, Aba, 
Sichuan 
5.00 8.47 0.81 3.48 2.57 2.46 2.60 11.80 0.24 0.30 
S13b 2015080900702 2.10 1.32 1.53 2.84 1.95 4.60 3.37 55.14 0.93 1.47 
S14a 2015072101501 Dege country, Aba, 
Sichuan 
6.00 7.66 1.17 3.52 4.03 3.96 3.49 15.45 0.49 1.05 
S14b 2015072101502 2.25 3.32 1.39 3.59 3.39 10.98 6.58 99.29 2.86 5.14 
S15a 2015070500401 Xianggelila Tibetan 
Hospital, Yunnan,  
2.96 3.13 1.46 3.62 2.21 10.86 2.60 31.16 0.74 1.30 
S15b 2015070500402 3.45 2.73 2.82 5.44 1.63 26.20 3.30 56.34 1.57 2.57 
S16a 2015070601801 Xianggelila, Yunnan 3.32 1.97 0.47 4.95 3.39 1.89 2.88 23.22 0.65 1.15 
S16b 2015070601802 2.10 2.67 1.46 5.31 3.10 8.46 5.00 86.33 3.16 5.26 
“a”: Aerial part sample, “b”: root sample. (1): loganic acid, (2): chlorogenic acid, (3): loganin, (4): sweroside,  
(5): isochlorogenic acid A, (6): sylvestroside I, (7): isochlorogenic acid C, (8): cantleyoside, (9): dipsanosides B. (10):dipsanosides A
Tang et al 





   
   
   
Figure 3: Contents (mg/g) of 10 compounds in different medicinal parts from P. hookeri determined by the UPLC method. *, **and *** indicate p < 0.05, p < 0.01 and p < 0.001, 
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P. hookeri samples with lower levels are 
considered substandard and should not be used 
as a medicinal material for clinical application. In 
our previous study [25], we determined the total 
contents of oleanolic acid and ursolic acid in 32 
batches of aerial part samples and found that the 
contents were all higher than 0.20 %. 
Interestingly, none of the root samples reached 
the standard of the 2015 edition of the Chinese 
Pharmacopoeia. 
 
P. hookeri is a perennial herb that mainly grows 
at an altitude of 3200-5700 m on hillsides and in 
grasslands, meadows, and forests. Due to root 
excavation, it was listed as an endangered 
Tibetan medicine species in 2000. 
Understanding how to rationally use P. hookeri 
resources while preventing its depletion is an 
important issue. Therefore, the results of this 





The developed method is simple, accurate and 
reproducible, and can be used for the 
simultaneous determination of the contents of 10 
major compounds of P. hookeri. The findings 
demonstrate that there is variation in the 
chemical composition of the two parts of P. 
hookeri, and that loganic acid and cantleyoside 
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